Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or along with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to a new study.
Cancer
High-intensity exercise reduces male cancer mortality
Men who are more active and exercise harder are less likely to develop cancer and die, new research has shown.
High intensity exercise can reduce the likelihood of death from cancer
People who are more active and exercise harder are less likely to develop cancer and die, according to new research.
Adult cancer survivors have risk of psychological distress
Long-term survivors of cancer that developed in adulthood are at increased risk of experiencing serious psychological distress, according to a new American report.
Cervical screening in some ages may have little impact
Cervical screening for women aged 20 to 24 years has little or no impact on rates of invasive cervical cancer up to age 30, a new study has found.
‘Virtual’ colonoscopy effective alternative to traditional colonoscopy
Computed tomographic (CT) colonography may offer patients at increased risk of colorectal cancer an alternative to colonoscopy that is less invasive, is better-tolerated and has good diagnostic accuracy, according to a new study led by Italian doctors.
Wealth and ethnicity linked to screening
White British women are more likely to have had a cervical screening and there is more chance that women who own a car and/or home have had a mammogram, according to new research.
Topical use of colon cancer agent may improve appearance of aging skin
Topical application of the chemotherapy medication fluorouracil appears to reduce potentially precancerous skin patches and improve the appearance of sun-damaged skin, according to a new study.
Smoking costs higher than thought
The cost of smoking to the Irish health services for respiratory illnesses and other smoking-related conditions could be much higher than previously believed.
Bevacizumab significantly increases risk of gastrointestinal perforation
The addition of bevacizumab to cancer therapy significantly increases the risk of gastrointestinal perforation, according to a new study.